OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
June 25, 2010
Strong, skilled management is on the agenda as never before. Find out who made 2010's roster of high-potential change masters-and how they plan to lead the industry through the turbulent times ahead.
June 01, 2010
Emerging Pharma Leaders
The public-interest charity takes on pharma-influenced medicing and drug-resistant bacteria.
Social networking helps sponsors drive clinical trials recruitment.
Lewis Morris, top lawyer in HHS's office of inspector general, explains his new move to target pharma execs for serious and ongoing healthcare fraud.
Improving communication means appealing to physicians' heads as well as their hearts.
Pharma companies can maximize partnership benefits with social media.
FDA and industry seek to ensure drug quality in a world complicated by global outsourcing and theft.
From the Editor
Innovation in industry has always required a strong internal champion; the danger is a process led by the risk-adverse and externally-driven stakeholder consensus called "death by faint praise." Is this really what we mean by "bold partnerships?"